Delivery Platforms to Produce Better Therapeutics

Time: 12:25 pm
day: Day 2 Track A - Morning


  • Explore how cannabinoids, whilst potentiated to hold therapeutic benefit and administered in varying ways with both short and long-term side effects, more is not always better
  • Evaluate how for cannabinoids to truly become a medicine, patient risk needs to be minimized and delivery platforms have the potential to mitigate this risk
  • Understand NanoCelle® Medlab’s proprietary, patented delivery platform and how it will be used as an example of low efficacious dose with minimal side effects in over 1100 Australian patients